Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Revenue (Details)

v3.22.2.2
Summary of Significant Accounting Policies - Revenue (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Revenues $ 2,383 $ 2,371
License [Member]    
Revenues 1,800  
Bioprocessing (iBio CDMO) [Member]    
Revenues $ 583 $ 2,371